XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021   30,181,348      
Beginning balance at Dec. 31, 2021 $ 1,034,519 $ 30 $ 606,392 $ 428,260 $ (163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 3,737     3,737  
Unrealized gain (loss) on investment, net of taxes (181)       (181)
Stock-based compensation 1,532   1,552 (20)  
Issuance of restricted and deferred stock units (in shares)   37,879      
Issuance of restricted and deferred stock units (1,269)   (1,269)    
Employee stock purchase plan (in shares)   17,918      
Employee stock purchase plan 1,049   1,049    
Common stock issuance, net of costs (87)   (87)    
Dividends paid (10,882)     (10,882)  
Ending balance (in shares) at Mar. 31, 2022   30,237,145      
Ending balance at Mar. 31, 2022 1,028,418 $ 30 607,637 421,095 (344)
Beginning balance (in shares) at Dec. 31, 2021   30,181,348      
Beginning balance at Dec. 31, 2021 1,034,519 $ 30 606,392 428,260 (163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 40,329        
Ending balance (in shares) at Sep. 30, 2022   30,315,265      
Ending balance at Sep. 30, 2022 1,049,347 $ 30 614,226 435,856 (765)
Beginning balance (in shares) at Mar. 31, 2022   30,237,145      
Beginning balance at Mar. 31, 2022 1,028,418 $ 30 607,637 421,095 (344)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 11,558     11,558  
Unrealized gain (loss) on investment, net of taxes (248)       (248)
Stock-based compensation 1,018   1,041 (23)  
Issuance of restricted and deferred stock units (in shares)   10,529      
Issuance of restricted and deferred stock units (6)   (6)    
Common stock issuance, net of costs (6)   (6)    
Dividends paid (10,889)     (10,889)  
Ending balance (in shares) at Jun. 30, 2022   30,247,674      
Ending balance at Jun. 30, 2022 1,029,845 $ 30 608,666 421,741 (592)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 25,034     25,034  
Unrealized gain (loss) on investment, net of taxes (173)       (173)
Stock-based compensation 1,375   1,398 (23)  
Issuance of restricted and deferred stock units (in shares)   1,316      
Issuance of restricted and deferred stock units 13   13    
Employee stock purchase plan (in shares)   18,667      
Employee stock purchase plan 1,042   1,042    
Common stock issuance, net of costs (in shares)   47,608      
Common stock issuance, net of costs 3,107   3,107    
Dividends paid (10,896)     (10,896)  
Ending balance (in shares) at Sep. 30, 2022   30,315,265      
Ending balance at Sep. 30, 2022 $ 1,049,347 $ 30 614,226 435,856 (765)
Beginning balance (in shares) at Dec. 31, 2022 30,801,912 30,801,912      
Beginning balance at Dec. 31, 2022 $ 1,110,868 $ 31 651,004 458,356 1,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 11,530     11,530  
Unrealized gain (loss) on investment, net of taxes 93       93
Stock-based compensation 1,177   1,199 (22)  
Issuance of restricted and deferred stock units (in shares)   38,776      
Issuance of restricted and deferred stock units (1,538)   (1,538)    
Employee stock purchase plan (in shares)   16,410      
Employee stock purchase plan 1,080   1,080    
Common stock issuance, net of costs (in shares)   570,026      
Common stock issuance, net of costs 40,997   40,997    
Dividends paid (11,722)     (11,722)  
Ending balance (in shares) at Mar. 31, 2023   31,427,124      
Ending balance at Mar. 31, 2023 $ 1,152,485 $ 31 692,742 458,142 1,570
Beginning balance (in shares) at Dec. 31, 2022 30,801,912 30,801,912      
Beginning balance at Dec. 31, 2022 $ 1,110,868 $ 31 651,004 458,356 1,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income $ 66,038        
Ending balance (in shares) at Sep. 30, 2023 31,933,003 31,933,003      
Ending balance at Sep. 30, 2023 $ 1,220,253 $ 32 729,740 488,585 1,896
Beginning balance (in shares) at Mar. 31, 2023   31,427,124      
Beginning balance at Mar. 31, 2023 1,152,485 $ 31 692,742 458,142 1,570
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 18,286     18,286  
Unrealized gain (loss) on investment, net of taxes 8       8
Stock-based compensation 1,122   1,139 (17)  
Issuance of restricted and deferred stock units (in shares)   13,429      
Issuance of restricted and deferred stock units (20)   (20)    
Common stock issuance, net of costs (in shares)   290,477      
Common stock issuance, net of costs 22,782 $ 1 22,781    
Dividends paid (11,947)     (11,947)  
Ending balance (in shares) at Jun. 30, 2023   31,731,030      
Ending balance at Jun. 30, 2023 1,182,716 $ 32 716,642 464,464 1,578
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 36,222     36,222  
Unrealized gain (loss) on investment, net of taxes 318       318
Stock-based compensation 1,230   1,238 (8)  
Issuance of restricted and deferred stock units (in shares)   14,840      
Issuance of restricted and deferred stock units (706)   (706)    
Employee stock purchase plan (in shares)   17,712      
Employee stock purchase plan 1,061   1,061    
Common stock issuance, net of costs (in shares)   169,421      
Common stock issuance, net of costs 11,505   11,505    
Dividends paid $ (12,093)     (12,093)  
Ending balance (in shares) at Sep. 30, 2023 31,933,003 31,933,003      
Ending balance at Sep. 30, 2023 $ 1,220,253 $ 32 $ 729,740 $ 488,585 $ 1,896